Oxalic Acid

Oxalic Acid

SCHEMBL3263653

O=C([O-])C(=O)[O-].O=C([O-])C(=O)[O-].[Cs+].[Cs+].[Cs+].[Cs+].[Cs+].[Cs+].[Cs+].[O-]B([O-])[O-]

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CA4 P22748 4/20 0.58
FAHD1 Q6P587 1/20 0.58
MEN1 O00255 1/20 0.38
LDHA P00338 1/20 0.38
BLM P54132 1/20 0.38
KMT2A Q03164 1/20 0.38
CA1 P00915 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL4557544 0.95 CA4 (0.64) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL2703828 0.91 CA4 (0.58) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL38247 0.91 CA4 (0.58) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL4552864 0.91 CA4 (0.73) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL19371299 0.91 CA4 (0.58) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL16910377 0.87 CA4 (0.54) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL19096954 0.87 CA4 (0.54) CA4FAHD1MEN1LDHABLM
Bicarbonate SCHEMBL7513803 0.86 CA4 (0.50) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL72980 0.85
Oxalic Acid SCHEMBL30992041 0.85 CA4 (0.78) CA4FAHD1MEN1LDHABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040116384-A1 Method for the production of hydrogen bis(chelato) borates and alkali metal bis(chelato)borates CHEMETALL GMBH (DE) 2004-06-17 US claimed
EP-1377592-A1 METHOD FOR THE PRODUCTION OF HYDROGEN BIS(CHELATO)BORATES AND ALKALI METAL BIS(CHELATO)BORATES Chemetall GmbH (DE) 2004-01-07 EP claimed
WO-2002068433-A1 METHOD FOR THE PRODUCTION OF HYDROGEN BIS(CHELATO)BORATES AND ALKALI METAL BIS(CHELATO)BORATES CHEMETALL GMBH (DE) 2002-09-06 WO claimed
US-20150236379-A1 ADDITIVES FOR GALVANIC CELLS Rockwood Lithium GmbH (DE) 2015-08-20 US disclosed
US-7674911-B2 Method for the production of hydrogen-bis (chelato) borates and alkali metal-bis (chelato) borates CHEMETALL GMBH (DE) 2010-03-09 US disclosed
EP-1377592-B1 METHOD FOR THE PRODUCTION OF HYDROGEN BIS(CHELATO)BORATES AND ALKALI METAL BIS(CHELATO)BORATES CHEMETALL GMBH (DE) 2009-07-15 EP disclosed
CN-1329401-C Method for the production of hydrogen bis(chelato) borates and alkali metal bis(chelato)borates CHEMETALL GMBH (DE) 2007-08-01 CN disclosed
US-20070166622-A1 Method for the production of hydrogen-bis (chelato) borates and alkali metal-bis (chelalo) borates WIETELMANN ULRICH 2007-07-19 US disclosed
US-7208131-B2 Method for the production of hydrogen-bis(chelato) borates and alkali metal-bis(chelato)borates CHEMETALL GMBH (DE) 2007-04-24 US disclosed
CN-1606562-A Method for the production of hydrogen bis(chelato) borates and alkali metal bis(chelato)borates CHEMETALL GMBH (DE) 2005-04-13 CN disclosed
US-20040116384-A1 Method for the production of hydrogen bis(chelato) borates and alkali metal bis(chelato)borates CHEMETALL GMBH (DE) 2004-06-17 US disclosed
EP-1377592-A1 METHOD FOR THE PRODUCTION OF HYDROGEN BIS(CHELATO)BORATES AND ALKALI METAL BIS(CHELATO)BORATES Chemetall GmbH (DE) 2004-01-07 EP disclosed
WO-2002068433-A1 METHOD FOR THE PRODUCTION OF HYDROGEN BIS(CHELATO)BORATES AND ALKALI METAL BIS(CHELATO)BORATES CHEMETALL GMBH (DE) 2002-09-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070166622-A1 Method for the production of hydrogen-bis (chelato) borates and alkali metal-bis (chelalo) borates LPO, CBR3, ME1 CA4 82/4885FAHD1 4039/4885MEN1 2148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.